Florida Senate - 2016                        COMMITTEE AMENDMENT
       Bill No. CS for SB 938
       
       
       
       
       
       
                                Ì526230nÎ526230                         
       
                              LEGISLATIVE ACTION                        
                    Senate             .             House              
                  Comm: RCS            .                                
                  02/16/2016           .                                
                                       .                                
                                       .                                
                                       .                                
       —————————————————————————————————————————————————————————————————




       —————————————————————————————————————————————————————————————————
       The Committee on Commerce and Tourism (Bean) recommended the
       following:
       
    1         Senate Amendment 
    2  
    3         Delete lines 53 - 66
    4  and insert:
    5  a finished drug product containing any quantity of
    6  dextromethorphan in violation of this section is subject to a
    7  written warning for an initial violation and, for each
    8  subsequent violation, a civil citation imposing a fine of not
    9  more than $100, which shall accrue and may be recovered in a
   10  civil action brought by the local jurisdiction. A manufacturer,
   11  distributor, or retailer who demonstrates a good faith effort to
   12  comply with this section is not subject to citation.
   13         (b)An employee or representative of a manufacturer,
   14  distributor, or retailer who, during the course of the
   15  employee’s or representative’s employment or association with
   16  the manufacturer, distributor, or retailer, sells a finished
   17  drug product containing any quantity of dextromethorphan in
   18  violation of this section is subject to a written warning.
   19         (c)A person who possesses or receives a finished drug
   20  product containing any quantity of dextromethorphan in